➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Harvard Business School
Baxter
Mallinckrodt
Boehringer Ingelheim
Moodys
Express Scripts

Last Updated: September 24, 2020

DrugPatentWatch Database Preview

Methdilazine hydrochloride - Generic Drug Details

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

What are the generic drug sources for methdilazine hydrochloride and what is the scope of freedom to operate?

Methdilazine hydrochloride is the generic ingredient in two branded drugs marketed by Alpharma Us Pharms and Westwood Squibb, and is included in two NDAs. Additional information is available in the individual branded drug profile pages.

There are four drug master file entries for methdilazine hydrochloride.

Summary for methdilazine hydrochloride
US Patents:0
Tradenames:2
Applicants:2
NDAs:2
Drug Master File Entries: 4
Bulk Api Vendors: 30
Patent Applications: 323
DailyMed Link:methdilazine hydrochloride at DailyMed

US Patents and Regulatory Information for methdilazine hydrochloride

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Westwood Squibb TACARYL methdilazine hydrochloride SYRUP;ORAL 011950-007 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Alpharma Us Pharms METHDILAZINE HYDROCHLORIDE methdilazine hydrochloride SYRUP;ORAL 087122-001 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
Westwood Squibb TACARYL methdilazine hydrochloride TABLET;ORAL 011950-006 Approved Prior to Jan 1, 1982 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

AstraZeneca
Express Scripts
Boehringer Ingelheim
Dow
McKinsey
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.